![Thomas E. Jenkins](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas E.
Jenkins is the founder.
He founded Elysium Therapeutics, Inc. in 2013 and currently holds the title of Chief Scientific Officer.
He also held the position of Chief Scientific Officer & Vice President-Research at Signature Therapeutics, Inc. In terms of education, Dr. Jenkins obtained a doctorate degree from Stanford University and an undergraduate degree from the University of Akron.
| Unternehmen | Position | Beginn |
|---|---|---|
Elysium Therapeutics, Inc.
 Elysium Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development in biotechnology | Gründer | 01.01.2013 |
| Unternehmen | Position | Ende |
|---|---|---|
Signature Therapeutics, Inc.
 Signature Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Technik-/Wissenschafts-/F&E-Leiter | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 4 |
|---|---|
Signature Therapeutics, Inc.
Signature Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Akron
 University of Akron Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Elysium Therapeutics, Inc.
Elysium Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
